300434 金石亚药
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.6355.39910.0413.242-28.960
总资产报酬率 ROA (%)1.3264.0967.5082.527-24.025
投入资产回报率 ROIC (%)1.4944.7999.0382.961-27.372

边际利润分析
销售毛利率 (%)56.86161.38661.33156.74253.890
营业利润率 (%)12.51314.71523.4978.446-85.932
息税前利润/营业总收入 (%)11.30513.68523.1008.633-85.951
净利润/营业总收入 (%)7.2769.98317.1456.275-88.058

收益指标分析
经营活动净收益/利润总额(%)110.745141.79098.556134.423-0.262
价值变动净收益/利润总额(%)-7.829-10.410-4.119-10.3390.235
营业外收支净额/利润总额(%)-6.536-0.521-0.4924.868-0.429

偿债能力分析
流动比率 (X)3.3172.2821.8611.8202.598
速动比率 (X)2.5851.8851.5701.4012.059
资产负债率 (%)13.93621.84124.72521.8960.174
带息债务/全部投入资本 (%)2.8248.5757.7405.2934.507
股东权益/带息债务 (%)3,341.3141,033.3911,152.0381,718.4792,035.153
股东权益/负债合计 (%)611.820354.374300.602343.786463.497
利息保障倍数 (X)-25.666-14.336-82.064-35.094222.655

营运能力分析
应收账款周转天数 (天)29.35525.73522.53717.22320.742
存货周转天数 (天)188.844167.902155.491161.018169.614